Similarly, a previous study found that selective inhibition of histone deacetylase 2 (HDAC2) causes downregulation of BIRC5 through activation of p53, which is mediated by the downregulation of MDM2 in lung cancer (Seo et al., 2015). Here, TP53 is linked to lung cancer.